181 related articles for article (PubMed ID: 36893630)
1. Shortages of agents used to treat antimuscarinic delirium.
Whitledge JD; Soto P; Glowacki KM; Fox ER; Mazer-Amirshahi M
Am J Emerg Med; 2023 May; 67():163-167. PubMed ID: 36893630
[TBL] [Abstract][Full Text] [Related]
2. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.
Whitledge JD; Watson CJ; Simpson M; Bakkar A; Boussi L; Scott M; Boyle KL
J Med Toxicol; 2023 Apr; 19(2):219-223. PubMed ID: 36575250
[TBL] [Abstract][Full Text] [Related]
3. Trends in Shortages of Lead Chelators From 2001 to 2022.
Whitledge JD; Soto P; Glowacki KM; Calello DP; Fox ER; Mazer-Amirshahi M
J Pediatr Pharmacol Ther; 2024 Jun; 29(3):306-315. PubMed ID: 38863853
[TBL] [Abstract][Full Text] [Related]
4. Drug shortages: Implications for medical toxicology.
Mazer-Amirshahi M; Hawley KL; Zocchi M; Fox E; Pines JM; Nelson LS
Clin Toxicol (Phila); 2015 Jul; 53(6):519-24. PubMed ID: 25951876
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pediatric antimuscarinic delirium with oral rivastigmine.
Yakey B; Vohra V; Martin A; King AM
Oxf Med Case Reports; 2023 Sep; 2023(9):omad096. PubMed ID: 37771682
[TBL] [Abstract][Full Text] [Related]
6. Shortage of generic neurologic therapeutics: An escalating threat to patient care.
Omorodion JO; Algahtani RM; Zocchi MS; Fox ER; Pines JM; Kaminski HJ
Neurology; 2017 Dec; 89(24):2431-2437. PubMed ID: 29142086
[TBL] [Abstract][Full Text] [Related]
7. Rivastigmine for the management of anticholinergic delirium.
Chiew AL; Holford AG; Chan BSH; Isoardi KZ
Clin Toxicol (Phila); 2024 Feb; 62(2):82-87. PubMed ID: 38465631
[TBL] [Abstract][Full Text] [Related]
8. Prescription Drug Shortages: Impact on Neonatal Intensive Care.
Ziesenitz VC; Fox E; Zocchi M; Samiee-Zafarghandy S; van den Anker JN; Mazer-Amirshahi M
Neonatology; 2019; 115(2):108-115. PubMed ID: 30384374
[TBL] [Abstract][Full Text] [Related]
9. Prescription Drug Shortages: Pediatric Emergency and Critical Care Medications.
Donnelly KA; Zocchi MS; Katy TA; Fox ER; Pines JM; van den Anker JN; Mazer-Amirshahi ME
Pediatr Emerg Care; 2021 Nov; 37(11):e726-e731. PubMed ID: 30829846
[TBL] [Abstract][Full Text] [Related]
10. US drug shortages compared to the World Health Organization's Model List of Essential Medicines for Children: A cross-sectional study.
Patel R; Samiee-Zafarghandy S; Ziesenitz V; Fox ER; Van Den Anker J; Ong H; Mazer-Amirshahi M
Am J Health Syst Pharm; 2022 Nov; 79(22):2012-2017. PubMed ID: 35913934
[TBL] [Abstract][Full Text] [Related]
11. Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report.
Fratta KA; Ginder M; Haggerty DA
J Emerg Med; 2023 Oct; 65(4):e366-e368. PubMed ID: 37716903
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome.
Wang GS; Baker K; Ng P; Janis GC; Leonard J; Mistry RD; Heard K
Clin Toxicol (Phila); 2021 Aug; 59(8):698-704. PubMed ID: 33295809
[TBL] [Abstract][Full Text] [Related]
13. U.S. vaccine and immune globulin product shortages, 2001-15.
Ziesenitz VC; Mazer-Amirshahi M; Zocchi MS; Fox ER; May LS
Am J Health Syst Pharm; 2017 Nov; 74(22):1879-1886. PubMed ID: 28970246
[TBL] [Abstract][Full Text] [Related]
14. Prolonged Antimuscarinic Delirium in a Child Due to Benztropine Exposure Treated With Multiple Doses of Physostigmine.
Thornton SL; Farnaes L; Minns A
Pediatr Emerg Care; 2016 Apr; 32(4):243-5. PubMed ID: 26383155
[TBL] [Abstract][Full Text] [Related]
15. The empty code cart: Drug shortages over time.
Gentile T; Snee I; Heinrichs D; Hockstein MA; Mazer-Amirshahi M; Fox ER
Am J Health Syst Pharm; 2024 May; ():. PubMed ID: 38800925
[TBL] [Abstract][Full Text] [Related]
16. Prescription Drug Shortages: Implications for Ambulatory Pediatrics.
Donnelly KA; Zocchi MS; Katy TA; Fox ER; van den Anker JN; Mazer-Amirshahi ME
J Pediatr; 2018 Aug; 199():65-70. PubMed ID: 29752177
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial drug shortages from 2001 to 2013: implications for clinical practice.
Quadri F; Mazer-Amirshahi M; Fox ER; Hawley KL; Pines JM; Zocchi MS; May L
Clin Infect Dis; 2015 Jun; 60(12):1737-42. PubMed ID: 25908680
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal trends in U.S. shortages of sterile solutions, 2001-17.
Mazer-Amirshahi M; Fox ER; Zocchi MS; Pines JM; van den Anker JN
Am J Health Syst Pharm; 2018 Dec; 75(23):1903-1908. PubMed ID: 30463866
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Anticholinergic Delirium with Oral Rivastigmine: A Case Report.
Karousatos C; Murphy L
J Emerg Med; 2024 May; 66(5):e589-e591. PubMed ID: 38658202
[TBL] [Abstract][Full Text] [Related]
20. Rivastigmine Use in the Treatment of Antimuscarinic Delirium.
Greene SC
J Med Toxicol; 2023 Jul; 19(3):284-287. PubMed ID: 37204613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
